News Archive

May 2016

May 17, 2016 Starpharma to present at ASX CEO Session

May 16, 2016 Australian Olympic Team taking Dual Protect™ VivaGel® Condoms to Rio

May 05, 2016 VivaGel® active against Zika virus

Apr 2016

Apr 28, 2016 Appendix 4C - Quarterly Cashflow Report

Apr 13, 2016 Shareholder Update April 2016

Apr 05, 2016 Starpharma to present at Bio-Europe conference

Apr 04, 2016 DEP cabazitaxel shows complete and sustained tumour regression in breast cancer model

Mar 2016

Mar 17, 2016 Adama Licenses Starpharma's Priostar for Novel 2,4-D

Mar 09, 2016 AAP: Starpharma licenses VivaGel BV in Aust, NZ

Mar 04, 2016 Starpharma licences VivaGel® BV to Aspen for ANZ

Feb 2016

Feb 17, 2016 Interim Report and Half-Yearly Financial Results

Feb 02, 2016 Targeted DEP™ shows sustained superior performance

Jan 2016

Jan 28, 2016 Appendix 4C - Quarterly Cashflow Report

Jan 20, 2016 Starpharma raises $1.9M under Share Purchase Plan

Dec 2015

Dec 17, 2015 The Age: Starpharma set for condom sales in China

Dec 16, 2015 Share Purchase Plan Offer Documents

Dec 16, 2015 Starpharma signs MOU for VivaGel condom in China

Dec 09, 2015 Starpharma completes A$32 million placement - SPP to follow

Dec 02, 2015 Second DEP™ candidate selected by AstraZeneca

Nov 2015

Nov 19, 2015 AGM - Chair address and CEO presentation

Nov 17, 2015 The Australian: Cancer trial results prove good medicine for biotech's stocks

Nov 16, 2015 Targeted DEP™ outperforms leading treatments in ovarian cancer model

Nov 12, 2015 Starpharma receives $3.4M R&D tax incentive refund

Nov 04, 2015 Starpharma to present at Bio-Europe® conference

Oct 2015

Oct 30, 2015 Appendix 4C - Quarterly Cashflow Report

Oct 29, 2015 Shareholder Update October 2015

Oct 14, 2015 Additional US Patent Granted for VivaGel® BV

Oct 01, 2015 OTCQX Life Sciences Presentation

Sep 2015

Sep 24, 2015 The Australian: Starpharma wins EU approval for VivaGel

Sep 24, 2015 EU Marketing Approval Granted for VivaGel® BV

Sep 17, 2015 The Wall Street Journal/The Australian: Australia looks to health care as a remedy for resource slump doldrums

Sep 16, 2015 The Wall Street Journal: 5 Things to know about Australia's biotech push

Sep 08, 2015 ABC's The Business: Interview with Dr Jackie Fairley following AstraZeneca deal

Sep 08, 2015 The Australian: Starpharma signs AstraZeneca deal

Sep 08, 2015 The Age and SMH: Starpharma shares soar 21 percent on AstraZeneca deal news

Sep 07, 2015 Starpharma signs drug delivery license with AstraZeneca

Aug 2015

Aug 20, 2015 Annual Report and full year financial results

Jul 2015

Jul 30, 2015 Appendix 4C - Quarterly Cashflow Report

Jun 2015

Jun 18, 2015 The Australian: Innovative companies 'need a super boost'

Jun 17, 2015 AFR and Brisbane Times: Starpharma finds star backers

May 2015

May 22, 2015 Starpharma TV

May 18, 2015 Seeking Alpha - Dendrimers Coming of Age: Starpharma's Star is Rising

May 06, 2015 Herald Sun: Stars aligning for biotech with all the trappings

May 04, 2015 AstraZeneca to develop oncology drug using SPL’s DEP™ technology

Apr 2015

Apr 30, 2015 Appendix 4C - Quarterly Cashflow Report

Apr 30, 2015 DEP™ Docetaxel Trial Dose Exceeds Common Taxotere® Dose Level

Apr 27, 2015 Herald Sun: Star turn for Carlton and United Breweries

Apr 08, 2015 Channel 9 News: Starpharma’s DEP™ docetaxel drug

Mar 2015

Mar 23, 2015 Shareholder Update March 2015

Mar 05, 2015 Starpharma to present at March US investor conferences